The SV postdoc association and the BioScience Network Lausanne (BSNL) together with the Association for Postdoc in Natural Sciences (APNS) at UNIL are gladly continuing our collaboration with the Novartis Institute for Biomedical Research (NIBR) in Basel: the Novartis-EPFL-UNIL (NEU) Meeting.
The 6th NEU meeting will take place on the 3rd of December 2018 (Monday) in Basel.
The aim of this meeting is to promote interactions among researchers conducting similar types of research in academia and in industry. In addition, this year an HR representative will present information on the ideal profile of a job candidate for Novartis.
PhD students and postdocs will have the opportunity to present their work and learn about research at NIBR. Besides, participants will attend exclusive lab visits at NIBR.
Please note that this meeting is not meant to be a job fair.
The tentative layout of the day is as follows:
- arrival in Basel at 9.45 AM (costs of transportation are on the participants)
- 3 presentations by NIBR scientists
- lunch break with poster presentations by EPFL/UNIL/NIBR scientists
- 1 presentation by EPFL/UNIL scientists
- 1 presentation by NIBR scientist
- 1 presentation by an HR representative
- NIBR lab visits
- departure to Lausanne around 6 PM
We are looking for PhD students and postdocs from EPFL and UNIL performing research in life science. You will have the opportunity to present a poster or give a talk (20 minutes) and we kindly ask you to submit an abstract (300 words max, no figures) following registration. Please note that you will need your advisors permission to present your work at NIBR.
The registration is open now and the deadline is on the 1st of November 2018. After registration we will send you a link for abstract submission. Abstracts have to be submitted by latest of 10th of November 2018. Your abstracts will be treated confidential and the organising committee will select participants based on their abstracts. The results of the selection will be communicated by 19th of November 2018.
Leave a Reply